Baseline characteristics: mean (SD) for continuous variables and number (%) for categorical variables by trial arm.

a<p>n = 348.</p>b<p>n = 330.</p>c<p>n = 354.</p>d<p>n = 348.</p>e<p>n = 351.</p>f<p>n = 344.</p>g<p>n = 370.</p>h<p>n = 362.</p>I<p>n = 375.</p>j<p>n = 364.</p

Progression to type 2 diabetes by trial arm.

<p>Progression to type 2 diabetes by trial arm.</p

Forest plot comparison of the three studies contributing to the EDIPS data-set.

<p>Forest plot comparison of the three studies contributing to the EDIPS data-set.</p

CONSORT Flow chart - recruitment by trial cohort and progress of participants.

<p>The flow chart refers to participants in the EDIPS study with impaired glucose tolerance at baseline.</p

EDIPS cases identified by high-risk FINDRISC¹⁰ score or by cut-points for fasting plasma glucose (FPG) and glycated Haemoglobin (HbA1c) as specified by NICE, ADA and WHO with risk statistics for intervention and control groups compared.

<p>EDIPS cases identified by high-risk FINDRISC¹⁰ score or by cut-points for fasting plasma glucose (FPG) and glycated Haemoglobin (HbA1c) as specified by NICE, ADA and WHO with risk statistics for intervention and control groups compared.</p

EDIPS cases identified by FINDRISC¹⁰ and high risk cut-points for fasting plasma glucose (FPG) and glycated Haemoglobin (HbA1c) as specified by NICE, ADA and WHO with risk statistics for intervention and control groups compared.

a<p>n = 717.</p>b<p>n = 732.</p

Progression to type 2 diabetes by weight loss achieved and maintained.

<p>Progression to type 2 diabetes by weight loss achieved and maintained.</p